Navigation Links
Axiom Worldwide Delists and Terminates US FDA 510(k)s for the DRX9000 Series of Products
Date:8/21/2012

TAMPA, Fla., Aug. 21, 2012 /PRNewswire-iReach/ -- On August 20th, 2012, Mr. James Gibson, President & CEO of Axiom Worldwide, Inc. offered further clarification regarding the status of Axiom's US FDA 510(k)s. Although Axiom Worldwide, Inc. still maintains ownership of its Intellectual Property, specifically the 510(k)s, Axiom discontinued manufacturing operations in the USA but did not sell or transfer the 510(k)s; therefore, in accordance with the Federal Laws governing Medical Device Manufacturers, and as required by the US Code of Federal Regulations, Axiom took the required legal steps necessary to delist and terminate the DRX9000 series of devices to prevent any counterfeit manufacturing of these products worldwide.  It was confirmed on April 29, 2011 that the FDA was in receipt of the filings by Axiom.  The delisting and termination was further confirmed in July of 2012 when Mr. Gibson gave several days of testimony to federal investigators of the US FDA. These required FDA device delistings of 510(k) cleared devices are done in an effort to protect unsuspecting hospitals and doctors from purchasing illegal equipment not covered by an authentic 510(K), and more importantly, to protect the safety of consumers.

(Photo:  http://photos.prnewswire.com/prnh/20120821/CG60866)

According to the US Food Drug and Cosmetic Act, a 510(k) is a premarket submission made to the FDA to demonstrate that the device to be marketed is at least as safe and effective, that is, substantially equivalent, to a legally marketed device. Under Section 510(k) of the Act, a company that wants to market in the US, a Class I, II, and III device intended for human use, for which a Premarket Approval (PMA) is not required, must submit a 510(k) to the FDA prior to commercial distribution. Federal law prohibits the commercial distribution of products such as the D
'/>"/>

SOURCE Axiom Worldwide
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. AspenBio Pharma Executes Worldwide License Agreement for its Animal Health Assets
2. BioMed Diagnostics Microbiology Diagnostic Devices Now Available Worldwide Through Distribution Agreement With VWR International, LLC
3. Mesenchymal Stem Cell Research Activity Rose 116% in 2011; Businesses Turning to BioInformant Worldwide for MSC Market Research
4. Chimerix Signs Worldwide License Agreement With Merck For CMX157, A Novel Candidate For The Treatment Of HIV
5. Misonix Exhibits at Major Worldwide Spine Conference
6. NicOx Signs Worldwide Licensing Agreement With Rapid Pathogen Screening, Inc. For Ophthalmic Diagnostics
7. Kansas City Region Launches Contract Research Initiative To Speed The Development Of Health Care Innovation Worldwide
8. Cephasonics Inks Distribution Deal With Tritech To Extend Worldwide Sales Reach Into Israel
9. Worldwide Multicenter Experiences with CardioFocus HeartLight® EAS to be Presented at Heart Rhythm 2012
10. Telemedicine Monitoring: Market Shares, Strategies, and Forecasts, Worldwide, 2012 to 2018
11. ResearchMoz: Telemedicine Monitoring Market Shares, Strategies, and Forecasts, Worldwide, 2012 to 2018 - Market Research Report
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... July 6, 2015 Cardinal Health today announced ... Group (THDG). A distributor of generic pharmaceuticals, over-the-counter medications and ... THDG was owned by Court Square Capital Partners. The ... cash and new debt.  Headquartered in ... Group had revenues of approximately $450 million in 2014. ...
(Date:7/6/2015)... Research and Markets( http://www.researchandmarkets.com/research/58tdl6/pharmaceutical ) has ... Chloride Market by Applications, by Region - Industry Trends ... The pharmaceutical grade sodium chloride market is ... and 2019 in terms of volume, and the consumption ... The report on Pharmaceutical grade sodium chloride market, ...
(Date:7/6/2015)... -- Celtaxsys, Inc., a clinical stage pharmaceutical development company ... orphan inflammatory disease indications, announced today that it has ... (FDA) to begin a Phase 2 clinical trial of ... patients in the US. The regulatory submissions to the ... be filed soon after. This groundbreaking clinical study, testing ...
Breaking Medicine Technology:Cardinal Health Completes Acquisition Of The Harvard Drug Group For $1.115 Billion 2Cardinal Health Completes Acquisition Of The Harvard Drug Group For $1.115 Billion 3Global Pharmaceutical Grade Sodium Chloride Market Report 2015 2Global Pharmaceutical Grade Sodium Chloride Market Report 2015 3Celtaxsys, Inc. Gains FDA Clearance for Landmark Phase 2 Trial of Anti-Inflammatory Treatment for Cystic Fibrosis (CF) 2Celtaxsys, Inc. Gains FDA Clearance for Landmark Phase 2 Trial of Anti-Inflammatory Treatment for Cystic Fibrosis (CF) 3
(Date:7/6/2015)... ... 06, 2015 , ... With a new community program in ... with Family Emergency Shelter Coalition (FESCO) and announced a new charity campaign to ... to provide emergency services and support for homeless families, all the while moving ...
(Date:7/6/2015)... (PRWEB) , ... July 06, 2015 , ... In a ... learn how to reduce their risk of having a fracture through the bone health ... Fractures Awareness Day. , “We are participating because our residents need this information to ...
(Date:7/6/2015)... ... July 06, 2015 , ... The School of Public Health ... a three-year effort to reduce rates of diabetes and cardiovascular disease in African-American ... the Morehouse School of Medicine’s Prevention Research Center and the Satcher Health Leadership ...
(Date:7/6/2015)... MD (PRWEB) , ... July 06, 2015 , ... Dr. ... and Washington, DC, area patients. Kybella is a non-surgical method to dissolve ... use of reducing moderate to severe fat deposits under the chin, commonly known as ...
(Date:7/6/2015)... (PRWEB) , ... July 06, 2015 , ... ... Dr. Jeffrey R. Carlson finished his 100th case using SpineFrontier’s® PedFuse® REmind® Screws. ... Immaculate Hospital in Newport News, VA. The procedure was an L5-S1 posterior lumbar ...
Breaking Medicine News(10 mins):Health News:Carlson & Associates Insurance Agency and Nonprofit Family Emergency Shelter Coalition (FESCO) Initiate New Charity Campaign in Alameda County, CA to Provide for Homeless 2Health News:Carlson & Associates Insurance Agency and Nonprofit Family Emergency Shelter Coalition (FESCO) Initiate New Charity Campaign in Alameda County, CA to Provide for Homeless 3Health News:National Bone Health Screening and Awareness Day 2Health News:Georgia State, Morehouse Partner To Tackle Diabetes, Heart Disease In Atlanta’s Minority Communities 2Health News:Rockville, MD Practice Now Offering New FDA-Approved Non-Surgical Double Chin Treatment 2Health News:100th Outpatient Less Exposure Surgery Procedure Completed by Industry Leading Surgeon Dr. Jeffrey Carlson 2Health News:100th Outpatient Less Exposure Surgery Procedure Completed by Industry Leading Surgeon Dr. Jeffrey Carlson 3
... following is being,issued by the U.S. Conference of Catholic ... Visit to the United States, WHO: Deirdre McQuade ... bishops of the United States. She is available for ... and New York,City., During his first U.S. visit, ...
... those who took 2,000 IUs a day lived 26% longer ... consume very high levels of vitamin E seem to live ... The study comes on the heels of growing concerns regarding ... suffering from Alzheimer,s or another illness -- the high dosage ...
... As the State of Nebraska,s Chief,Medical Officer, ... large-scale,public health issues. The same goes for Gary ... University Medical Center. Right now, both,physicians are focusing ... (Photo: http://www.newscom.com/cgi-bin/prnh/20080415/LATU118LOGO ), Dr. Schaefer, ...
... 24, NAPA, Calif., April 15 Senetek PLC ... the development,of technologies that target the science of healthy ... December 31, 2007., Revenue for the year ended ... 2006. Revenues for the fourth quarter of 2007,were $223,000, ...
... minutes during their,workday, DALLAS, April 15 April ... The call to action is,simple: Americans should fit 30 ... that American jobs have become more sedentary and that,employees ... did 20 years ago. The,Start! movement works with employers ...
... to the European Advertising and Medical Education ... ... healthcare marketing,executive with more than 15 years strategic and business-building,experience, has joined ... Development, Europe. GHG Grey,Healthcare Group (GHG) is a WPP company and one ...
Cached Medicine News:Health News:High Doses of Vitamin E Lengthen Lives of Alzheimer's Patients 2Health News:High Doses of Vitamin E Lengthen Lives of Alzheimer's Patients 3Health News:Two Prominent Nebraska Doctors Become Patients in Living Donor Liver Transplant 2Health News:Two Prominent Nebraska Doctors Become Patients in Living Donor Liver Transplant 3Health News:Two Prominent Nebraska Doctors Become Patients in Living Donor Liver Transplant 4Health News:Senetek PLC Reports 2007 Financial Results 2Health News:Senetek PLC Reports 2007 Financial Results 3Health News:Start! Walking America: The American Heart Association's National Start! Walking Day Is April 16 2Health News:Start! Walking America: The American Heart Association's National Start! Walking Day Is April 16 3Health News:Susan Byrne joins GHG Grey Healthcare Group as EVP, Strategy and Business Development, Europe, a Newly-Created Position 2
... ring electrodes feature a molded grip ... slider that moves smoothly and locks ... also feature ultraflexible, red-and-black, 61-cm (24-in) ... resistance of bend-relief protection at both ...
... bars made of silver/silver chloride have contacts ... easy separation into two individual tabs. For ... 17). Bar dimensions: 4 cm (1.6 in) ... 200-count package contains 50 individually sealed sets ...
... Video Camera System (NTSC)With Maxenon PowerPlus ... surgeon's eye view of any procedure. ... or digital files for later use. ... 8" to 36". Automatic Iris and ...
... and your patient warm, with the ... system.,Designed around the Coanda Effect, thousands ... air flow around your torso's blush ... the heat and stress induced environment ...
Medicine Products: